Skip to main content
Top
Published in: Acta Neuropathologica 6/2010

01-12-2010 | Original Paper

Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features

Authors: Giorgio Giaccone, Michela Morbin, Fabio Moda, Mario Botta, Giulia Mazzoleni, Andrea Uggetti, Marcella Catania, Maria Luisa Moro, Veronica Redaelli, Alberto Spagnoli, Roberta Simona Rossi, Mario Salmona, Giuseppe Di Fede, Fabrizio Tagliavini

Published in: Acta Neuropathologica | Issue 6/2010

Login to get access

Abstract

Mutations of three different genes, encoding β-amyloid precursor protein (APP), presenilin 1 and presenilin 2 are associated with familial Alzheimer’s disease (AD). Recently, the APP mutation A673V has been identified that stands out from all the genetic defects previously reported in these three genes, since it causes the disease only in the homozygous state (Di Fede et al. in Science 323:1473–1477, 2009). We here provide the detailed neuropathological picture of the proband of this family, who was homozygous for the APP A673V mutation and recently came to death. The brain has been studied by histological and immunohistochemical techniques, at the optical and ultrastructural levels. Cerebral Aβ accumulation and tau pathology were severe and extensive. Peculiar features were the configuration of the Aβ deposits that were of large size, mostly perivascular and exhibited a close correspondence between the pattern elicited by amyloid stainings and the labeling obtained with immunoreagents specific for Aβ40 or Aβ42. Moreover, Aβ deposition spared the neostriatum while deeply affecting the cerebellum, and therefore was not in compliance with the hierarchical topographical sequence of involvement documented in sporadic AD. Therefore, the neuropathological picture of familial AD caused by the APP recessive mutation A673V presents distinctive characteristics compared to sporadic AD or familial AD inherited as a dominant trait. Main peculiar features are the morphology, structural properties and composition of the Aβ deposits as well as their topographic distribution in the brain.
Literature
1.
go back to reference Basun H, Bogdanovic N, Ingelsson M et al (2008) Clinical and neuropathological features of the Arctic APP gene mutation causing early-onset Alzheimer disease. Arch Neurol 65:499–505CrossRefPubMed Basun H, Bogdanovic N, Ingelsson M et al (2008) Clinical and neuropathological features of the Arctic APP gene mutation causing early-onset Alzheimer disease. Arch Neurol 65:499–505CrossRefPubMed
2.
go back to reference Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMed Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMed
3.
go back to reference Bruni AC, Bernardi L, Colao R et al (2010) Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation. Neurology 74:798–806CrossRefPubMed Bruni AC, Bernardi L, Colao R et al (2010) Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation. Neurology 74:798–806CrossRefPubMed
4.
go back to reference Bugiani O, Giaccone G, Rossi G et al (2010) Hereditary cerebral hemorrhage with amyloidosis associated with E693K mutation of APP. Arch Neurol 67:987–995CrossRefPubMed Bugiani O, Giaccone G, Rossi G et al (2010) Hereditary cerebral hemorrhage with amyloidosis associated with E693K mutation of APP. Arch Neurol 67:987–995CrossRefPubMed
5.
go back to reference Cras P, van Harskamp F, Hendriks L et al (1998) Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala → Gly mutation. Acta Neuropathol 96:253–260CrossRefPubMed Cras P, van Harskamp F, Hendriks L et al (1998) Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala → Gly mutation. Acta Neuropathol 96:253–260CrossRefPubMed
6.
go back to reference Cupidi C, Capobianco R, Goffredo D et al (2010) Neocortical variation of Aβ load in fully expressed, pure Alzheimer disease. J Alzheimers Dis 19:57–68PubMed Cupidi C, Capobianco R, Goffredo D et al (2010) Neocortical variation of Aβ load in fully expressed, pure Alzheimer disease. J Alzheimers Dis 19:57–68PubMed
7.
go back to reference Di Fede G, Catania M, Morbin M et al (2009) A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 323:1473–1477CrossRefPubMed Di Fede G, Catania M, Morbin M et al (2009) A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 323:1473–1477CrossRefPubMed
8.
go back to reference Duyckaerts C, Delatour B, Potier M-C (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118:5–36CrossRefPubMed Duyckaerts C, Delatour B, Potier M-C (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118:5–36CrossRefPubMed
9.
go back to reference Fukumoto H, Asami-Odaka A, Suzuki N, Shimada H, Ihara Y, Iwatsubo T (1996) Amyloid β protein deposition in normal aging has the same characteristics as that in Alzheimer’s disease. Predominance of Aβ42(43) and association of Aβ40 with cored plaques. Am J Pathol 148:259–265PubMed Fukumoto H, Asami-Odaka A, Suzuki N, Shimada H, Ihara Y, Iwatsubo T (1996) Amyloid β protein deposition in normal aging has the same characteristics as that in Alzheimer’s disease. Predominance of Aβ42(43) and association of Aβ40 with cored plaques. Am J Pathol 148:259–265PubMed
10.
go back to reference Goate A, Chartier-Harlin MC, Mullan M et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349:704–706CrossRefPubMed Goate A, Chartier-Harlin MC, Mullan M et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349:704–706CrossRefPubMed
11.
go back to reference Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49:697–705CrossRefPubMed Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49:697–705CrossRefPubMed
12.
go back to reference Hardy GA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 286:184–185CrossRef Hardy GA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 286:184–185CrossRef
13.
go back to reference Iwatzubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13:45–53CrossRef Iwatzubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13:45–53CrossRef
14.
go back to reference Kumar-Singh S, De Jonghe C, Cruts M et al (2000) Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated Abeta(42) in Alzheimer’s disease. Hum Mol Gen 9:2589–2598CrossRefPubMed Kumar-Singh S, De Jonghe C, Cruts M et al (2000) Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated Abeta(42) in Alzheimer’s disease. Hum Mol Gen 9:2589–2598CrossRefPubMed
15.
go back to reference Lannfelt L, Bogdanovic N, Appelgren H et al (1994) Amyloid precursor protein mutation causes Alzheimer’s disease in a Swedish family. Neurosci Lett 168:254–256CrossRefPubMed Lannfelt L, Bogdanovic N, Appelgren H et al (1994) Amyloid precursor protein mutation causes Alzheimer’s disease in a Swedish family. Neurosci Lett 168:254–256CrossRefPubMed
16.
go back to reference Levy E, Carman MD, Fernandez-Madrid IJ et al (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124–1126CrossRefPubMed Levy E, Carman MD, Fernandez-Madrid IJ et al (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124–1126CrossRefPubMed
17.
go back to reference Mann DM, Takeuchi A, Sato S et al (2001) Cases of Alzheimer’s disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as ‘cotton wool’ plaques. Neuropathol Appl Neurobiol 27:189–196CrossRefPubMed Mann DM, Takeuchi A, Sato S et al (2001) Cases of Alzheimer’s disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as ‘cotton wool’ plaques. Neuropathol Appl Neurobiol 27:189–196CrossRefPubMed
18.
go back to reference Mann DMA, Pickering-Brown SM, Takeuchi A et al (2001) Amyloid angiopathy and variability in amyloid β deposition is determined by mutation position in Presenilin-1-linked Alzheimer’s disease. Am J Pathol 158:2165–2175PubMed Mann DMA, Pickering-Brown SM, Takeuchi A et al (2001) Amyloid angiopathy and variability in amyloid β deposition is determined by mutation position in Presenilin-1-linked Alzheimer’s disease. Am J Pathol 158:2165–2175PubMed
19.
go back to reference Marcon G, Giaccone G, Cupidi C et al (2004) Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene. J Neuropathol Exp Neurol 63:199–209PubMed Marcon G, Giaccone G, Cupidi C et al (2004) Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene. J Neuropathol Exp Neurol 63:199–209PubMed
20.
go back to reference Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer’s disease. Neurology 41:479–486PubMed Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer’s disease. Neurology 41:479–486PubMed
21.
go back to reference Obici L, Demarchi A, de Rosa G et al (2005) A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. Ann Neurol 58:639–644CrossRefPubMed Obici L, Demarchi A, de Rosa G et al (2005) A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. Ann Neurol 58:639–644CrossRefPubMed
22.
go back to reference Piscopo P, Marcon G, Piras MR et al (2008) A novel PSEN2 mutation associated with a peculiar phenotype. Neurology 70:1549–1554CrossRefPubMed Piscopo P, Marcon G, Piras MR et al (2008) A novel PSEN2 mutation associated with a peculiar phenotype. Neurology 70:1549–1554CrossRefPubMed
23.
go back to reference Rossi G, Giaccone G, Maletta R et al (2004) A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene. Neurology 63:910–912PubMed Rossi G, Giaccone G, Maletta R et al (2004) A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene. Neurology 63:910–912PubMed
24.
go back to reference Rovelet-Lecrux A, Hannequin D, Raux G et al (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24–26CrossRefPubMed Rovelet-Lecrux A, Hannequin D, Raux G et al (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24–26CrossRefPubMed
25.
go back to reference Scholz W (1938) Studien zur Pathologie der Hirngefäße. II: die drusige Entartung der Hirnarterien und Capillaren. Z Gesamte Neurol Psychiatr 162:694–715CrossRef Scholz W (1938) Studien zur Pathologie der Hirngefäße. II: die drusige Entartung der Hirnarterien und Capillaren. Z Gesamte Neurol Psychiatr 162:694–715CrossRef
26.
go back to reference Seubert P, Vigo-Pelfrey C, Esch F et al (1992) Isolation and quantification of soluble Alzheimer’s β-peptide from biological fluids. Nature 359:325–327CrossRefPubMed Seubert P, Vigo-Pelfrey C, Esch F et al (1992) Isolation and quantification of soluble Alzheimer’s β-peptide from biological fluids. Nature 359:325–327CrossRefPubMed
27.
go back to reference Shepherd C, McCann H, Halliday GM (2009) Variations in the neuropathology of familial Alzheimer’s disease. Acta Neuropathol 118:37–52CrossRefPubMed Shepherd C, McCann H, Halliday GM (2009) Variations in the neuropathology of familial Alzheimer’s disease. Acta Neuropathol 118:37–52CrossRefPubMed
28.
go back to reference Tagliavini F, Giaccone G, Frangione B, Bugiani O (1988) Preamyloid deposits in the cerebral cortex of patients with Alzheimer’s disease and nondemented individuals. Neurosci Lett 93:191–196CrossRefPubMed Tagliavini F, Giaccone G, Frangione B, Bugiani O (1988) Preamyloid deposits in the cerebral cortex of patients with Alzheimer’s disease and nondemented individuals. Neurosci Lett 93:191–196CrossRefPubMed
29.
go back to reference Takao M, Ghetti B, Murrel JR et al (2001) Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures. J Neuropathol Exp Neurol 60:1137–1152PubMed Takao M, Ghetti B, Murrel JR et al (2001) Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures. J Neuropathol Exp Neurol 60:1137–1152PubMed
30.
go back to reference Thal DR, Rűb U, Orantes M, Braak H (2002) Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed Thal DR, Rűb U, Orantes M, Braak H (2002) Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed
31.
go back to reference Van Duinen SG, Castaño EM, Prelli F, Bots GT, Luyendijk W, Frangione B (1987) Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc Natl Acad Sci USA 84:5991–5994CrossRefPubMed Van Duinen SG, Castaño EM, Prelli F, Bots GT, Luyendijk W, Frangione B (1987) Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc Natl Acad Sci USA 84:5991–5994CrossRefPubMed
32.
go back to reference Villemagne VL, Ataka S, Mizuno T et al (2009) High striatal amyloid β-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol 66:1537–1544CrossRefPubMed Villemagne VL, Ataka S, Mizuno T et al (2009) High striatal amyloid β-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol 66:1537–1544CrossRefPubMed
Metadata
Title
Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features
Authors
Giorgio Giaccone
Michela Morbin
Fabio Moda
Mario Botta
Giulia Mazzoleni
Andrea Uggetti
Marcella Catania
Maria Luisa Moro
Veronica Redaelli
Alberto Spagnoli
Roberta Simona Rossi
Mario Salmona
Giuseppe Di Fede
Fabrizio Tagliavini
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 6/2010
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-010-0747-1

Other articles of this Issue 6/2010

Acta Neuropathologica 6/2010 Go to the issue